UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Unlocking the Goldenseal Reveals the Complexities of Natural Product-Drug Interactions

The Journal of pharmacology and experimental therapeutics, 2023-12, Vol.387 (3), p.249-251

2023

Volltextzugriff (PDF)

More Than an Adipokine: The Complex Roles of Chemerin Signaling in Cancer

International journal of molecular sciences, 2019-09, Vol.20 (19), p.4778

2019

Volltextzugriff (PDF)

The Effects of CKD on Cytochrome P450–Mediated Drug Metabolism

Advances in chronic kidney disease, 2016-03, Vol.23 (2), p.67-75

2016

Volltextzugriff (PDF)

Chemerin Exacerbates Glucose Intolerance in Mouse Models of Obesity and Diabetes

Endocrinology (Philadelphia), 2010-05, Vol.151 (5), p.1998-2007

2010

Volltextzugriff (PDF)

Chemerin, a Novel Adipokine That Regulates Adipogenesis and Adipocyte Metabolism

The Journal of biological chemistry, 2007-09, Vol.282 (38), p.28175-28188

2007

Volltextzugriff (PDF)

Jadomycin B Acts Synergistically with NSAIDs to Produce Cytotoxic Effects in Human Breast Cancer Cells in vitro

The FASEB journal, 2022-05, Vol.36 (S1), p.n/a

2022

Volltextzugriff (PDF)

The impact of COVID-19 infection on cytochrome P450 3A4-mediated drug metabolism and drug interactions

Expert opinion on drug metabolism & toxicology, 2023, Vol.ahead-of-print (ahead-of-print), p.1-4

2023

Volltextzugriff (PDF)

COVID-19 Vaccines and the Virus: Impact on Drug Metabolism and Pharmacokinetics

Drug metabolism and disposition, 2023-01, Vol.51 (1), p.130-141

2023

Volltextzugriff (PDF)

Serum Chemerin Levels Vary with Time of Day and Are Modified by Obesity and Tumor Necrosis Factor-α

Endocrinology (Philadelphia), 2010-06, Vol.151 (6), p.2590-2602

2010

Volltextzugriff (PDF)

Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer

Drug metabolism and disposition, 2008-02, Vol.36 (2), p.205-216

2008

Volltextzugriff (PDF)

Antitumor Activity of Abnormal Cannabidiol and Its Analog O-1602 in Taxol-Resistant Preclinical Models of Breast Cancer

Frontiers in pharmacology, 2019-09, Vol.10, p.1124-1124

2019

Volltextzugriff (PDF)

Elastase and tryptase govern TNFα-mediated production of active chemerin by adipocytes

PloS one, 2012-12, Vol.7 (12), p.e51072-e51072

2012

Volltextzugriff (PDF)

COVID-19 pathophysiology and pharmacology: what do we know and how did Canadians respond? A review of Health Canada authorized clinical vaccine and drug trials

Canadian journal of physiology and pharmacology, 2021-06, Vol.99 (6), p.577-588

2021

Volltextzugriff (PDF)

Chemerin, a Novel Peroxisome Proliferator-activated Receptor γ (PPARγ) Target Gene That Promotes Mesenchymal Stem Cell Adipogenesis

The Journal of biological chemistry, 2011-07, Vol.286 (27), p.23982-23995

2011

Volltextzugriff (PDF)

Metabolism and pharmacokinetics of a novel polyphenol fatty acid ester phloridzin docosahexaenoate in Balb/c female mice

Scientific reports, 2020-12, Vol.10 (1), p.21391-12, Article 21391

2020

Volltextzugriff (PDF)

Biliopancreatic diversion with duodenal switch modifies plasma chemerin in early and late post‐operative periods

Obesity (Silver Spring, Md.), 2015-06, Vol.23 (6), p.1201-1208

2015

Volltextzugriff (PDF)

Jadomycins: A potential chemotherapy for multi‐drug resistant metastatic breast cancer

Pharmacology research & perspectives, 2021-12, Vol.9 (6), p.e00886-n/a

2021

Volltextzugriff (PDF)

S100B as a biomarker of blood–brain barrier disruption after thoracoabdominal aortic aneurysm repair: a secondary analysis from a prospective cohort study

Canadian journal of anesthesia, 2021-12, Vol.68 (12), p.1756-1768

2021

Volltextzugriff (PDF)

Jadomycins Inhibit Type II Topoisomerases and Promote DNA Damage and Apoptosis in Multidrug-Resistant Triple-Negative Breast Cancer Cells

The Journal of pharmacology and experimental therapeutics, 2017-11, Vol.363 (2), p.196-210

2017

Volltextzugriff (PDF)

Decitabine Response in Breast Cancer Requires Efficient Drug Processing and Is Not Limited by Multidrug Resistance

Molecular cancer therapeutics, 2020-05, Vol.19 (5), p.1110-1122

2020

Volltextzugriff (PDF)

A critical overview of the influence of inflammation and infection on P-glycoprotein expression and activity in the brain

Expert opinion on drug metabolism & toxicology, 2008-10, Vol.4 (10), p.1245-1264

2008

Volltextzugriff (PDF)

Pilot study of jadomycin B pharmacokinetics and anti-tumoral effects in zebrafish larvae and mouse breast cancer xenograft models

Canadian journal of physiology and pharmacology, 2022-11, Vol.100 (11), p.1065-1076

2022

Volltextzugriff (PDF)

Correction: Pilot study of jadomycin B pharmacokinetics and anti-tumoral effects in zebrafish larvae and mouse breast cancer xenograft models

Canadian journal of physiology and pharmacology, 2023-04, Vol.101 (4), p.214-214

2023

Volltextzugriff (PDF)

Isolation of a jadomycin incorporating l-ornithine, analysis of antimicrobial activity and jadomycin reactive oxygen species (ROS) generation in MDA-MB-231 breast cancer cells

Journal of antibiotics, 2018-08, Vol.71 (8), p.722-730

2018

Volltextzugriff (PDF)

The role of sex, age and genetic polymorphisms of CYP enzymes on the pharmacokinetics of anticholinergic drugs

Pharmacology research & perspectives, 2021-05, Vol.9 (3), p.e00775-n/a

2021

Volltextzugriff (PDF)

1 – 25 von 78

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(55)

Publikationsform

Sprache

Englisch
(78)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(50)
Life Sciences & Biomedicine
(46)
Animals
(31)
Pharmacology & Pharmacy
(27)
Humans
(24)
Male
(18)
Female
(16)
Biological And Medical Sciences
(15)
Mice
(15)
Obesity
(11)
Inflammation
(9)
Medical Sciences
(9)
Rats
(9)
Fundamental And Applied Biological Sciences. Psychology
(8)
Pharmacology
(8)
Rats, Sprague-Dawley
(8)
Biochemistry & Molecular Biology
(7)
Breast Cancer
(7)
Chemokines
(7)
Inflammation - Metabolism
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Unlocking the Goldenseal Reveals the Complexities of Natural Product-Drug Interactions

More Than an Adipokine: The Complex Roles of Chemerin Signaling in Cancer

The Effects of CKD on Cytochrome P450–Mediated Drug Metabolism

Chemerin Exacerbates Glucose Intolerance in Mouse Models of Obesity and Diabetes

Chemerin, a Novel Adipokine That Regulates Adipogenesis and Adipocyte Metabolism

Jadomycin B Acts Synergistically with NSAIDs to Produce Cytotoxic Effects in Human Breast Cancer Cells in vitro

The impact of COVID-19 infection on cytochrome P450 3A4-mediated drug metabolism and drug interactions

COVID-19 Vaccines and the Virus: Impact on Drug Metabolism and Pharmacokinetics

Serum Chemerin Levels Vary with Time of Day and Are Modified by Obesity and Tumor Necrosis Factor-α

Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer

Antitumor Activity of Abnormal Cannabidiol and Its Analog O-1602 in Taxol-Resistant Preclinical Models of Breast Cancer

Elastase and tryptase govern TNFα-mediated production of active chemerin by adipocytes

COVID-19 pathophysiology and pharmacology: what do we know and how did Canadians respond? A review of Health Canada authorized clinical vaccine and drug trials

Chemerin, a Novel Peroxisome Proliferator-activated Receptor γ (PPARγ) Target Gene That Promotes Mesenchymal Stem Cell Adipogenesis

Metabolism and pharmacokinetics of a novel polyphenol fatty acid ester phloridzin docosahexaenoate in Balb/c female mice

Biliopancreatic diversion with duodenal switch modifies plasma chemerin in early and late post‐operative periods

Jadomycins: A potential chemotherapy for multi‐drug resistant metastatic breast cancer

S100B as a biomarker of blood–brain barrier disruption after thoracoabdominal aortic aneurysm repair: a secondary analysis from a prospective cohort study

Jadomycins Inhibit Type II Topoisomerases and Promote DNA Damage and Apoptosis in Multidrug-Resistant Triple-Negative Breast Cancer Cells

Decitabine Response in Breast Cancer Requires Efficient Drug Processing and Is Not Limited by Multidrug Resistance

A critical overview of the influence of inflammation and infection on P-glycoprotein expression and activity in the brain

Pilot study of jadomycin B pharmacokinetics and anti-tumoral effects in zebrafish larvae and mouse breast cancer xenograft models

Correction: Pilot study of jadomycin B pharmacokinetics and anti-tumoral effects in zebrafish larvae and mouse breast cancer xenograft models

Isolation of a jadomycin incorporating l-ornithine, analysis of antimicrobial activity and jadomycin reactive oxygen species (ROS) generation in MDA-MB-231 breast cancer cells

The role of sex, age and genetic polymorphisms of CYP enzymes on the pharmacokinetics of anticholinergic drugs

Suchergebnisse filtern